Factor V Leiden is a genetic disorder characterized by a poor anticoagulant response to
activated Protein C and an increased risk for venous thromboembolism. Deep venous …

Recurrent spontaneous miscarriage (RSM), affecting 1-2% of women of reproductive age
seeking pregnancy, has been a clinical quagmire and a formidable challenge for the treating …

Recurrent miscarriage affects 1–2% of women. In more than half of all recurrent miscarriage
the cause still remains uncertain. Thrombophilia has been identified in about 50% of women …

Miscarriage is defined as the spontaneous loss of pregnancy before the fetus reaches
viability. The term therefore includes all pregnancy losses from the time of conception until …

Women with recurrent pregnancy loss are offered Factor V Leiden (F5) and/or prothrombin
G20210A (F2) testing to identify candidates for anticoagulation to improve outcomes. A …

Background Although numerous replication case-control studies have attempted to
determine the association between Factor V Leiden (FVL) 1691G> A mutation and …

Purpose: Official guideline coordinated and published by the German Society of Gynecology
and Obstetrics (DGGG). Aim of the guideline was to standardize the diagnosis and treatment …

Background Unexplained recurrent spontaneous abortion (URSA) frustrates women of
childbearing age profoundly, and effective therapies are particularly important. Objective To …

Objective: To determine the association of factor V Leiden mutation with recurrent pregnancy
loss. Methods: The case-control study was conducted at the Department of Haematology …

AIMS: The aim of this study was to evaluate the prevalence and role of inherited
thrombophilia in early pregnancy loss, specifically in the first trimester. MATERIALS AND …